Dr Srikanth Reddy Sokkula : Driving Global Regulatory Excellence And Innovation In Pharmaceuticals
Dr Srikanth Reddy Sokkula
Head - Regulatory Affairs
By interpreting evolving guidelines across regions and embedding regulatory intelligence into business strategy, these leaders ensure that organizations remain competitive while delivering safe and effective products. In the pharmaceutical sector especially, their ability to balance speed, quality, and compliance directly impacts patient access and organizational success.
One such accomplished professional is Dr Srikanth Reddy Sokkula, Head of Regulatory Affairs at Jodas Expoim Pvt. Ltd. With over two decades of experience, he has established himself as a distinguished expert in pharmaceutical development and global regulatory strategy.
His career journey reflects extensive leadership across key markets including the EU, Australia, Canada, Brazil, and several emerging economies, where he has successfully guided diverse portfolios toward regulatory approvals.
Dr Sokkula’s expertise spans Global GMP audits, pharmacovigilance, and clinical and bio studies, alongside deep knowledge of parenteral preparations and oral solid dosage forms.
He has played a transformative role in building and leading cross functional teams that integrate regulatory intelligence with development, quality, and pharmaco -vigilance functions.
His contributions to advanced drug delivery systems, including liposomal and nano-formulations highlight his commitment to innovation and scientific excellence.
A recipient of the prestigious Dr APJ Abdul Kalam Excellence Award, Dr Sokkula is also widely recognized as an industry thought leader. Through keynote addresses, global conferences, and academic engagements, he continues to inspire and mentor the next generation of pharma -ceutical professionals while shaping the future of regulatory excellence worldwide. Let’s read.
What strategies have you adopted to consistently drive innovation, regulatory excellence, and global growth in the pharmaceutical sector?
I follow a balanced approach anchored in three key pillars. First, I prioritize proactive regulatory intelligence to anticipate evolving guidelines and stay ahead of change. Second, I build strong cross functional collaborations, ensuring regulatory insights are integrated early into R&D and extended functions.
Third, I maintain a global perspective while remaining sensitive to local market nuances. This combined strategy enables faster approvals and strengthens patient access across regions.
Ultimately, I view compliance not as a constraint but as a strategic lever that drives innovation, supports sustainable growth, and creates long-term value for both the organization and the patients we serve.
What trends are shaping the future of global regulatory frameworks and compliance?
I see an exciting shift toward greater agility and a stronger patient-centric focus in global regulatory frameworks. I observe how digital advancements, including AI-driven submissions and real-time analytics, are streamlining processes and improving efficiency.
At the same time, increasing harmonization across regions is helping bridge regulatory gaps and enable smoother global pathways.
I also note that advanced therapies and biosimilars are driving more sophisticated yet accessible approval mechanisms.
Strengthened pharmacovigilance and the adoption of Quality by Design principles are ensuring long-term product perfor-mance.
Additionally, sustainability is becoming an integral part of regulatory thinking, shaping a more collaborative, future-ready ecosystem.
Describe your leadership approach. What are the guidelines or methodologies you follow as a leader?
I believe leadership is fundamentally about empowering people and aligning them around a shared vision. I focus on creating clarity in goals, fostering collaboration, and instilling a strong sense of accountability across teams.
I encourage ownership at every level, as it drives innovation and builds confi -dence. I also promote a culture of continuous learning, where teams adapt and grow in a dynamic environment. My decisions are guided by data and grounded in integrity and transparency.
This approach helps teams navigate complexity effectively, achieve regulatory success and maintain strong organizational alignment while delivering consistent, high-impact outcomes.
I believe leadership is fundamentally about empowering people and aligning them around a shared vision
Third, I maintain a global perspective while remaining sensitive to local market nuances. This combined strategy enables faster approvals and strengthens patient access across regions.
Ultimately, I view compliance not as a constraint but as a strategic lever that drives innovation, supports sustainable growth, and creates long-term value for both the organization and the patients we serve.
What trends are shaping the future of global regulatory frameworks and compliance?
I see an exciting shift toward greater agility and a stronger patient-centric focus in global regulatory frameworks. I observe how digital advancements, including AI-driven submissions and real-time analytics, are streamlining processes and improving efficiency.
At the same time, increasing harmonization across regions is helping bridge regulatory gaps and enable smoother global pathways.
I also note that advanced therapies and biosimilars are driving more sophisticated yet accessible approval mechanisms.
Strengthened pharmacovigilance and the adoption of Quality by Design principles are ensuring long-term product perfor-mance.
Additionally, sustainability is becoming an integral part of regulatory thinking, shaping a more collaborative, future-ready ecosystem.
Describe your leadership approach. What are the guidelines or methodologies you follow as a leader?
I believe leadership is fundamentally about empowering people and aligning them around a shared vision. I focus on creating clarity in goals, fostering collaboration, and instilling a strong sense of accountability across teams.
I encourage ownership at every level, as it drives innovation and builds confi -dence. I also promote a culture of continuous learning, where teams adapt and grow in a dynamic environment. My decisions are guided by data and grounded in integrity and transparency.
This approach helps teams navigate complexity effectively, achieve regulatory success and maintain strong organizational alignment while delivering consistent, high-impact outcomes.
What is the future destination you are heading towards?
I am driven to expand my impact at a strategic global level by shaping forward-looking regulatory frameworks that enable faster access to safe and innovative medicines worldwide. I aim to contribute to emerging areas such as complex generics, advanced drug delivery systems, and digital health solutions, ensuring they are integrated effectively within evolving regulatory landscapes.
At the same time, I am passionate about mentoring future leaders and contributing to policy development that strengthens the industry as a whole. Ultimately, my goal is to enhance patient outcomes and play a meaningful role in advancing the promise of global healthcare.
Based on your extensive experience in the industry, what advice would you give to aspiring leaders in the field?
My advice to aspiring leaders is to build a strong foundation in regulatory guide lines and product development while viewing regulation as a strategic enabler rather than a limitation.
I encourage staying agile, curious, and open to learning across functions to gain a well-rounded perspective. Developing strong communication and decision-making skills early on is equally important for long-term success.
Above all, I believe in staying deeply patient-centric, as it remains the core purpose of everything we do. Keeping this focus ensures that innovations translate into meaningful outcomes, helping deliver safe and effective medicines to those who need them most.
Dr Srikanth Reddy Sokkula, Head-Regulatory Affairs, Jodas Expoim
Dr Srikanth Reddy Sokkula is a seasoned regulatory affairs leader with 20+ years in pharmaceuticals. As Head of Regulatory Affairs at Jodas Expoim Pvt. Ltd., he drives global strategies, specializes in advanced drug delivery systems, and is recognized for thought leadership, innovation, and mentoring future industry professionals.
•Achieved significantly reduced regulatory approval time lines, securing among the fastest approvals across European markets other SRA markets.
•Successfully managed multiple first-to-file generic applications including highly complex products requiring advanced regulatory strategy.
•Implemented streamlined submission processes, including CESP/Eudralink at Bluefish Pharmaceuticals AB, improving operational efficiency and compliance standards.
•Recognized as an award-winning industry speaker delivering impactful presentations at both national and international plat -forms.
I am driven to expand my impact at a strategic global level by shaping forward-looking regulatory frameworks that enable faster access to safe and innovative medicines worldwide. I aim to contribute to emerging areas such as complex generics, advanced drug delivery systems, and digital health solutions, ensuring they are integrated effectively within evolving regulatory landscapes.
At the same time, I am passionate about mentoring future leaders and contributing to policy development that strengthens the industry as a whole. Ultimately, my goal is to enhance patient outcomes and play a meaningful role in advancing the promise of global healthcare.
Based on your extensive experience in the industry, what advice would you give to aspiring leaders in the field?
My advice to aspiring leaders is to build a strong foundation in regulatory guide lines and product development while viewing regulation as a strategic enabler rather than a limitation.
I encourage staying agile, curious, and open to learning across functions to gain a well-rounded perspective. Developing strong communication and decision-making skills early on is equally important for long-term success.
Above all, I believe in staying deeply patient-centric, as it remains the core purpose of everything we do. Keeping this focus ensures that innovations translate into meaningful outcomes, helping deliver safe and effective medicines to those who need them most.
Dr Srikanth Reddy Sokkula, Head-Regulatory Affairs, Jodas Expoim
Dr Srikanth Reddy Sokkula is a seasoned regulatory affairs leader with 20+ years in pharmaceuticals. As Head of Regulatory Affairs at Jodas Expoim Pvt. Ltd., he drives global strategies, specializes in advanced drug delivery systems, and is recognized for thought leadership, innovation, and mentoring future industry professionals.
•Achieved significantly reduced regulatory approval time lines, securing among the fastest approvals across European markets other SRA markets.
•Successfully managed multiple first-to-file generic applications including highly complex products requiring advanced regulatory strategy.
•Implemented streamlined submission processes, including CESP/Eudralink at Bluefish Pharmaceuticals AB, improving operational efficiency and compliance standards.
•Recognized as an award-winning industry speaker delivering impactful presentations at both national and international plat -forms.